Cargando…

Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage

BACKGROUND: Azelnidipine (AZL), a long-acting dihydropyridine-based calcium antagonist, has been recently approved and used for treating ischemic heart disease and cardiac remodeling after myocardial infarction, however, its effect on hyperglycemia-induced cardiac damage has not been studied. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kain, Vasundhara, Kumar, Sandeep, Puranik, Amrutesh S, Sitasawad, Sandhya L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004822/ https://www.ncbi.nlm.nih.gov/pubmed/21118576 http://dx.doi.org/10.1186/1475-2840-9-82

Ejemplares similares

Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
por: Kain, Vasundhara, et al.
Publicado: (2011)

A novel SOD mimic with a redox-modulating mn (II) complex, ML1 attenuates high glucose-induced abnormalities in intracellular Ca(2+) transients and prevents cardiac cell death through restoration of mitochondrial function
por: Kain, Vasundhara, et al.
Publicado: (2016)

Multiple Antioxidants Improve Cardiac Complications and Inhibit Cardiac Cell Death in Streptozotocin-Induced Diabetic Rats
por: Kumar, Santosh, et al.
Publicado: (2013)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

Potential protective effects of Azelnidipine against cerebral ischemia-reperfusion injury in male rats
por: Fakharaldeen, Zainab, et al.
Publicado: (2022)

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
por: Chen, Bi-Lian, et al.
Publicado: (2015)

Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium
por: Rawal, Shruti, et al.
Publicado: (2019)

Monoamine oxidase A inhibition protects the myocardium after experimental acute volume overload
por: Huuskonen, Christa, et al.
Publicado: (2019)

Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility
por: Ku, Po-Ming, et al.
Publicado: (2011)

Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)
por: Tawaramoto, Kazuhito, et al.
Publicado: (2015)

miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism
por: Mahajan, Megharani, et al.
Publicado: (2021)

Gene Expression Networks in the Murine Pulmonary Myocardium Provide Insight into the Pathobiology of Atrial Fibrillation
por: Boutilier, Jordan K., et al.
Publicado: (2017)

Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents
por: Rodrigues, Bruno, et al.
Publicado: (2011)

Comparison of the physical and thermodynamic stability of amorphous azelnidipine and its coamorphous phase with piperazine
por: Du, Shuang, et al.
Publicado: (2018)

A case of complete atrioventricular block with extremely high blood concentration of azelnidipine
por: Ide, Naohito, et al.
Publicado: (2021)

Resveratrol Protects against Methylglyoxal-Induced Hyperglycemia and Pancreatic Damage In Vivo
por: Cheng, An-Sheng, et al.
Publicado: (2015)

Azelnidipine Inhibits Cultured Rat Aortic Smooth Muscle Cell Death Induced by Cyclic Mechanical Stretch
por: Zhao, Jing, et al.
Publicado: (2014)

Effects of Azelnidipine-Carboxymethylcellulose Gel on Healing of Full-Thickness Skin Wounds in Streptozotocin Induced Diabetic Rats
por: Karami, Mohammad Yasin, et al.
Publicado: (2019)

Possible Pharmacodynamic Interaction of Azelnidipine with Citicoline Against Ischemic Brain Injury: Behavioral, Biochemical and Histological Alterations
por: Gupta, Varun, et al.
Publicado: (2020)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
por: Takami, Takeshi, et al.
Publicado: (2013)

Ferulic Acid Protects Hyperglycemia-Induced Kidney Damage by Regulating Oxidative Insult, Inflammation and Autophagy
por: Chowdhury, Sayantani, et al.
Publicado: (2019)

Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on glucose tolerance and endothelial function - a crossover trial (AGENT)
por: Fukao, Kosuke, et al.
Publicado: (2011)

The effect of rutin on cisplatin-induced oxidative cardiac damage in rats
por: Topal, İsmail, et al.
Publicado: (2018)

Cassia auriculata: Aspects of Safety Pharmacology and Drug Interaction
por: Puranik, Amrutesh S., et al.
Publicado: (2011)

Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts
por: Matsumoto, Shuhei, et al.
Publicado: (2012)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial [Corrigendum]
Publicado: (2013)

Saikosaponin A protects against uremic toxin indole‑3 acetic acid‑induced damage to the myocardium
por: Chen, Cheng, et al.
Publicado: (2023)

Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium Channel
por: Komoda, Hiroshi, et al.
Publicado: (2018)

Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels
por: Qian, Haili
Publicado: (2022)

Vitamin C further improves the protective effect of GLP-1 on the ischemia-reperfusion-like effect induced by hyperglycemia post-hypoglycemia in type 1 diabetes
por: Ceriello, Antonio, et al.
Publicado: (2013)

Autophagy Attenuates Diabetic Glomerular Damage through Protection of Hyperglycemia-Induced Podocyte Injury
por: Fang, Li, et al.
Publicado: (2013)

Protective effects of aspirin and vitamin C against corn syrup consumption-induced cardiac damage through sirtuin-1 and HIF-1a pathway
por: Aşcı, Halil, et al.
Publicado: (2016)

Reference Genes for Expression Studies in Hypoxia and Hyperglycemia Models in Human Umbilical Vein Endothelial Cells
por: Bakhashab, Sherin, et al.
Publicado: (2014)

Baicalin protects the myocardium from reperfusion-induced damage in isolated rat hearts via the antioxidant and paracrine effect
por: KONG, FENG, et al.
Publicado: (2014)

TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction
por: Sun, Jing, et al.
Publicado: (2013)

Zinc-induced cardiomyocyte relaxation in a rat model of hyperglycemia is independent of myosin isoform
por: Yi, Ting, et al.
Publicado: (2012)

Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form
por: Patel, Jayvadan K, et al.
Publicado: (2014)

Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial
por: Takihata, Masahiro, et al.
Publicado: (2015)

Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp
por: Wang, Zhuang, et al.
Publicado: (2022)

Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
por: Zhao, Lili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ad55hctujigs0i9jk1atcsic5